Source: Annual Congress 2003 - Lung cancer surgery: prognostic factors



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sardari Nia, J. Hendriks, P. Vermeulen, E. Van Marck, P. E. Van Schil (Antwerp, Belgium). Biological classification of NSCLC, based on the vascular profile. Eur Respir J 2003; 22: Suppl. 45, 1445

Member's Comments

No comment yet.

Related content which might interest you: Validation and comparison of several published prognostic systems for patients with small cell lung cancer Source: Eur Respir J 2011; 38: 657-663 Year: 2011 Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases Year: 2014 A novel biologic classification of non-small cell lung cancer Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005 Epithelial growth factor receptor (EGFR) mutation status and the treatment of non-small cell lung cancer (NSCLC): A population based quality assurance analysis Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 136-142 Year: 2011 Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level? Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Gene expression profiling in non-small cell lung cancer (NSCLC) according to smoking status Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Prognostic relevance of the new lung cancer classification in operable stages Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science Year: 2014 Assessment of DNA ploidy and proliferating activity changes in neoplasmatic cells according to TNM classification and clinical stages in non-small cell lung cancer (NSCLC) patients during chemotherapy Source: Eur Respir J 2003; 22: Suppl. 45, 225s Year: 2003 Lung cancer biomarkers based on miRNA Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 A new TNM classification is better than ISS at predicting survival in stage III unresectable non-small cell lung cancer (NSCLC). A study by the European lung cancer working party (ELCWP) Source: Eur Respir J 2003; 22: Suppl. 45, 163s Year: 2003 Lepidic and non-lepidic adenocarcinomas have distinct gene expression signatures that correlate with aggressiveness Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Analysis of survival and characteristics of patients with non-small cell lung carcinoma (NSCLC) stage IV depending on molecular markers Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Biological factors predicting response to chemotherapy (CT) in advanced non small cell lung cancer (NSCLC): A feasibility study on the collection of tissue Source: Annual Congress 2010 - The role of biomarkers in lung cancer Year: 2010 Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer Year: 2013 Comprehensive evaluation of nuclear factor-κΒ expression patterns in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015